Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Medical Director
Merck Sharp & Dohme LLC
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
282 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Británico de Buenos Aires-Oncology ( Site 0202)
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Recruiting - Instituto de Investigaciones Clínicas Mar del Plata ( Site 0201)
Mar del Plata, Buenos Aires, Argentina
Recruiting - Asociación de Beneficencia Hospital Sirio Libanés ( Site 0205)
Buenos Aires, Buenos Aires F.D., Argentina
Recruiting - Instituto Alexander Fleming-Alexander Fleming ( Site 0206)
Buenos Aires, Buenos Aires F.D., Argentina
Recruiting - Sanatorio Parque ( Site 0208)
Rosario, Santa Fe Province, Argentina
Recruiting - Hospital Aleman-Oncology ( Site 0207)
Buenos Aires, Argentina
Recruiting - Fundacion Centro Oncologico de Integración Regional-Medical Oncology ( Site 0204)
Mendoza, Argentina
Active, not recruiting
- Dubbo Hospital ( Site 0235)
Dubbo, New South Wales, Australia
Recruiting - Macquarie University-Mq Health Clinical Trials Unit ( Site 0234)
Macquarie University, New South Wales, Australia
Recruiting - Westmead Hospital ( Site 0232)
Westmead, New South Wales, Australia
Active, not recruiting - Princess Alexandra Hospital-Cancer Care Serices ( Site 0237)
Brisbane, Queensland, Australia
Recruiting - Peter Maccallum Cancer Centre-Parkville Cancer Clinical Trials Unit (pcctu) ( Site 0230)
Melbourne, Victoria, Australia
Active, not recruiting
- Medizinische Universität Graz-Innere Medizin Klin. Abt. Onkologie ( Site 0280)
Graz, Styria, Austria
Recruiting - Ordensklinikum Linz Gmbh Elisabethinen-Urologie ( Site 0276)
Linz, Upper Austria, Austria
Recruiting - Klinikum Wels-Grieskirchen Gmbh ( Site 0279)
Wels, Upper Austria, Austria
Recruiting
- Hospital Santa Rita de Cassia-Centro de Pesquisa Clínica ( Site 0320)
Vitória, Espírito Santo, Brazil
Recruiting - Obras Sociais Irma Dulce ( Site 0302)
Salvador, Estado de Bahia, Brazil
Active, not recruiting - Hospital Felicio Rocho ( Site 0317)
Belo Horizonte, Minas Gerais, Brazil
Recruiting - Hospital Mario Penna ( Site 0309)
Belo Horizonte, Minas Gerais, Brazil
Active, not recruiting - Hospital Universitário Evangélico Mackenzie-Centro de Oncologia Mackenzie ( Site 0314)
Curitiba, Paraná, Brazil
Active, not recruiting - Clínica de Neoplasias Litoral ( Site 0305)
Itajaí, Santa Catarina, Brazil
Recruiting - Hospital Universitário São Francisco de Assis - Bragança Paulista ( Site 0308)
Bragança Paulista, São Paulo, Brazil
Active, not recruiting - A. C. Camargo Cancer Center ( Site 0310)
São Paulo, São Paulo, Brazil
Active, not recruiting
- Cross Cancer Institute ( Site 0332)
Edmonton, Alberta, Canada
Recruiting - the Ottawa Hospital - General Campus-the Ottawa Hospital Cancer Centre ( Site 0336)
Ottawa, Ontario, Canada
Recruiting - Princess Margaret Cancer Centre ( Site 0330)
Toronto, Ontario, Canada
Recruiting - Sunnybrook Research Institute ( Site 0331)
Toronto, Ontario, Canada
Recruiting - Centre Intégré de Santé Et de Services Sociaux de la Montérégie-Centre ( Site 0328)
Greenfield Park, Quebec, Canada
Recruiting - Centre Hospitalier de L'Université de Montréal ( Site 0326)
Montreal, Quebec, Canada
Active, not recruiting - Centre Intégré de Cancérologie Du Chu de Québec Université Laval, Hôpital de L'Enfant-Jésus ( Site 0327)
Québec, Quebec, Canada
Recruiting - Centre Intégré Universitaire de Santé Et de Services Sociaux de L'Estrie - Centre Hospitalier Univer ( Site 0329)
Sherbrooke, Quebec, Canada
Active, not recruiting
- Ic la Serena Research ( Site 0356)
La Serena, Coquimbo Region, Chile
Active, not recruiting - Clinical Research Chile Spa ( Site 0358)
Valdivia, Los Ríos Region, Chile
Active, not recruiting - Clinica Universidad Catolica del Maule-Oncology ( Site 0355)
Talca, Maule Region, Chile
Recruiting - Bradfordhill-Clinical Area ( Site 0351)
Santiago, Region M. de Santiago, Chile
Recruiting - Falp ( Site 0353)
Santiago, Region M. de Santiago, Chile
Active, not recruiting - Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 0354)
Santiago, Region M. de Santiago, Chile
Recruiting - Bradford Hill Norte ( Site 0357)
Antofagasta, Chile
Active, not recruiting
- Second Affiliated Hospital of Anhui Medical University-Urology ( Site 0408)
Hefei, Anhui, China
Recruiting - Beijing Cancer Hospital-Urinary Surgery ( Site 0395)
Beijing, Beijing Municipality, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2023
- Primary completion
- 2 Aug 2028
- Completion
- 15 Feb 2030
- Last update posted
- 5 May 2026
- Registered enrollment
- 1,310
- Registry id
- NCT06136624
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.